C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 49.2 KBCTI BIOPHARMA CORPDec 18, 4:41 PM ET·0000891293-15-000070
- 48.9 KBCTI BIOPHARMA CORPOct 1, 7:26 PM ET·0000891293-15-000052
- 411.7 KBCTI BIOPHARMA CORPOct 1, 7:13 PM ET·0000891293-15-000051
- 45.9 KBCTI BIOPHARMA CORPOct 1, 6:49 PM ET·0000891293-15-000050
- 420.7 KBCTI BIOPHARMA CORPOct 1, 6:21 PM ET·0000891293-15-000048
- 422.8 KBCTI BIOPHARMA CORPOct 1, 5:58 PM ET·0000891293-15-000047
- 8-K42.8 KBCELL THERAPEUTICS INCJan 6, 6:10 AM ET·0001193125-14-002197
- 8-K32.7 KBCELL THERAPEUTICS INCJan 2, 6:05 AM ET·0001193125-14-000055
- 8-K38.3 KBCELL THERAPEUTICS INCJan 3, 5:11 PM ET·0001193125-12-000976
- SC 13G858.7 KBCELL THERAPEUTICS INCJan 24, 5:10 PM ET·0001144204-11-003714
Insiders
10- ASELAGE STEVEEVP, Global Commercial Ops
- BAUER JOHN HDirector
- Bianco James A.Director, CEO
- BIANCO LOUIS AEVP, Finance & Administration
- BOWMAN JACK LDirector
- Brown JadeEVP, Chief Business Officer
- CANFIELD JAMESChief Administrative Officer
- Eramian Daniel GEVP, Corporate Communications
- FLUKE JOHN M JRDirector
- GREGORIAN VARTANDirector
Tickers
No tickers on record
Addresses
business
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121
mailing
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121
Former Names
- CELL THERAPEUTICS INC2014-05-29